PASSERI DANIEL R 4
4 · Cue Biopharma, Inc. · Filed Feb 12, 2020
Insider Transaction Report
Form 4
PASSERI DANIEL R
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Restricted Stock Units
2020-02-05+150,000→ 150,000 total→ Common Stock (150,000 underlying) - Award
Stock Option (right to buy)
2020-02-05+150,000→ 150,000 totalExercise: $16.26Exp: 2030-02-05→ Common Stock (150,000 underlying)
Footnotes (3)
- [F1]This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 5, 2020.
- [F2]Each restricted stock unit award represents a contingent right to receive one share of common stock.
- [F3]One-half of the restricted stock units vest on September 30, 2021 and the balance vest on March 31, 2022.